| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 05/29/2002 | CN1351052A Polypeptide-kringle protein 59.62 and polynucleotide for coding it |
| 05/29/2002 | CN1351051A Polypeptide-human tumor lethal factor receptor associated factor 8.91 and polynucleotide for coding it |
| 05/29/2002 | CN1351050A Polypeptide-insuline-like growth factor bindin 11.77 and polynucleotide for coding it |
| 05/29/2002 | CN1351049A Polypeptide-humn RNA splicing factor htra2-beta protein 43.23 and polynucleotide for coding it |
| 05/29/2002 | CN1351048A Polypeptide-human nucleotide excision repair protein 10.67 and polynucleotide for coding it |
| 05/29/2002 | CN1351047A Polypeptide-human synaptic vesicle protein 12.98 and polynucleotide for coding it |
| 05/29/2002 | CN1351046A Polypeptide-human transcriptional coactivator 37.07 and polynucleotide for coding it |
| 05/29/2002 | CN1351045A Polypeptide-Dhml protein 10.56 and polynucleotide for coding it |
| 05/29/2002 | CN1351044A Polypeptide-human retinoblastoma bindin 11.33 and polynucleotide for coding it |
| 05/29/2002 | CN1351043A Polypeptide-bone growth/differentiation factor 59.68 and polynucleotide for coding it |
| 05/29/2002 | CN1351042A Polypeptide-human ribosomal protein L1210.56 and polynucleotide for coding it |
| 05/29/2002 | CN1351041A Polypeptide-human euchromosome fragile intelligence delay syndrome associated protein 20.02 and polynucleotide for coding it |
| 05/29/2002 | CN1351040A Polypeptide-human cyclin G220.46 and polynucleotide for coding it |
| 05/29/2002 | CN1351039A Polypeptide-human zinc finger protein 29.70 and polynucleotide for coding it |
| 05/29/2002 | CN1351038A Polypeptide-human B-class complementary phosphatidylol glycan 11.33 and polynucleotide for coding it |
| 05/29/2002 | CN1351037A Polypeptide-human signal recognition particle 729.68 and polynucleotide for coding it |
| 05/29/2002 | CN1351036A Polypeptide-human XY chromosome associated protein 31.35 and polynucleotide for coding it |
| 05/29/2002 | CN1351035A Polypeptide-human phosphatidase A2-activator protein 24.09 and polynucleotide for coding it |
| 05/29/2002 | CN1351034A Polypeptide-human FD16.06 and polynucleotide for coding it |
| 05/29/2002 | CN1351033A Polypeptide-human neural cell adherent protein 9.79 and polynucleotide for coding it |
| 05/29/2002 | CN1351032A Polypeptide-human glycoprotein 12.54 and polynucleotide for coding it |
| 05/29/2002 | CN1351031A Polypeptide-human Eps8 bindin e3B 114.74 and polynucleotide for coding it |
| 05/29/2002 | CN1351030A Polypeptide-sulfate protein polyose core protein 13.42 and polynucleotide for coding it |
| 05/29/2002 | CN1351029A Polypeptide-human protein 9.02 containing hydrogen peroxidase characteristic sequence fragment and polynucleotide for coding it |
| 05/29/2002 | CN1351028A Polypeptide-human protein 9.46 containing ATP synthase characteristic sequence fragment and polynucleotide for coding it |
| 05/29/2002 | CN1351027A Polypeptide-protein 16.17 containing colipase characteristics and polynucleotide for coding it |
| 05/29/2002 | CN1351026A Polypeptide-human protein 9.68 containing signal peptidase characteristic sequence fragment and polynucleotide for coding it |
| 05/29/2002 | CN1351025A Polypeptide-cytochyma recombinant cell antigen protein APK 131.57 and polynucleotide for coding it |
| 05/29/2002 | CN1351024A Polypeptide-protein 11.55 containing multiple TPR domain and polynucleotide for coding it |
| 05/29/2002 | CN1351023A Polypeptide-retinal rhabditis Na-Ca+K ion exchanger 11.33 and polynucleotide for coding it |
| 05/29/2002 | CN1351022A Polypeptide-ribosomal protein S18-11.66 and polynucleotide for coding it |
| 05/29/2002 | CN1351021A Polypeptide-bindin RanBP 10.23 and polynuceotide for coding it |
| 05/29/2002 | CN1351020A Polypeptide-AP-2 gamma transcription factor 9.13 and polynucleotide for coding it |
| 05/29/2002 | CN1351019A Polypeptide-symplekin 23.54 and polynucleotide for coding it |
| 05/29/2002 | CN1351018A Polypeptide-SR protein RNPS 143.1 and polynucleotide for coding it |
| 05/29/2002 | CN1351017A Polypeptide-zinc finger protein FPM 31510.23 and polynucleotide for coding it |
| 05/29/2002 | CN1351016A Polypeptide-protein 19.47 containing nucleoside diphosphate kinase activity site characteristics and polynucleotide for encoding it |
| 05/28/2002 | US6395960 A genetically engineered rodent; diagnosis and therapy for alzheimer's disease |
| 05/28/2002 | US6395883 Soluble morphogenic protein complex compositions of matter |
| 05/28/2002 | US6395882 Selectin ligands |
| 05/28/2002 | US6395879 Monoclonal antibodies against Campylobacter jejuni and Campylobacter coli outer membrane antigens |
| 05/28/2002 | US6395877 14273 receptor, a novel G-protein coupled receptor |
| 05/28/2002 | US6395874 A protein; therapy for strokes, arthritis, pulmonary adult respiratory distress syndrome, atherosclerosis and inflammation of the eye |
| 05/28/2002 | US6395548 Methods of modulating of angiogenesis |
| 05/28/2002 | US6395547 Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
| 05/28/2002 | US6395530 LLG polypeptides of the triacylglycerol lipase family, and compositions and methods for their use in enzymatic hydrolysis, and protein and gene therapies |
| 05/28/2002 | US6395515 Directed switch-mediated DNA recombination |
| 05/28/2002 | US6395512 DNA coding for a peptide of a papilloma virus main capside protein and use thereof |
| 05/28/2002 | US6395511 Nuclelotide sequences coding regulatory protein; for usein treatment of bone disorders |
| 05/28/2002 | US6395510 Vertebrate apoptosis gene: compositions and methods |
| 05/28/2002 | US6395500 Antibodies for the detection of beer spoilage lactic acid bacteria and kit employing the antibodies |
| 05/28/2002 | US6395499 Methods of identifying modulators of a DP prostaglandin receptor |
| 05/28/2002 | US6395498 Methods of identifying compounds that modulate body weight using the OB receptor |
| 05/28/2002 | US6395497 Suppression of leukocyte transferring in humans; administer immunoglobulins to humans, detect bound receptor, evaluate immune response |
| 05/28/2002 | US6395494 Method to determine TGF-β |
| 05/28/2002 | US6395474 Peptide nucleic acids |
| 05/28/2002 | US6395282 Carrier molecule conjugated to specific autoinducers; vaccines for the treatment and prevention of infection |
| 05/28/2002 | US6395276 Killing malignant b cells by contacting with protein having ribonuclease activity linked to antibody against b cell surface marker; anticancer agents |
| 05/28/2002 | US6395275 Synthetic human neutralizing monoclonal antibodies to human immunodeficiency virus |
| 05/28/2002 | US6395274 Administering murine anti-human interleukin-5 monoclonal antibody, binding fragment or chimeric binding molecule to human to modulate inflammation; antiinflammatory agents |
| 05/28/2002 | US6395273 Orally administering polyclonal antibodies against tumor necrosis factor to mammal to reduce symptoms |
| 05/28/2002 | US6395272 Therapeutic compounds comprised of anti-Fc receptor antibodies |
| 05/28/2002 | US6395267 Inhibiting signal transduction in tumor necrosis factor receptors by identifying molecule that binds to specific amino acid sequence of human receptor, then bringing molecule in contact with receptor |
| 05/28/2002 | CA2121256C Secreted mac-2-binding glycoprotein |
| 05/28/2002 | CA2092533C Nucleotide sequences coding for a human protein with angiogenesis regulative properties |
| 05/28/2002 | CA2071651C A parenterally administrable drug having thrombolytic activity and containing protein c |
| 05/28/2002 | CA2032653C Cytotoxic lymphocyte maturation factor and monoclonal antibodies directed thereto |
| 05/23/2002 | WO2002040720A2 Compositions and methods relating to ovary specific genes and proteins |
| 05/23/2002 | WO2002040683A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 05/23/2002 | WO2002040676A2 Mutant allergens |
| 05/23/2002 | WO2002040671A2 Immunoglobulin superfamily proteins |
| 05/23/2002 | WO2002040668A2 Proteins and dna sequences underlying these proteins used for treating inflammations |
| 05/23/2002 | WO2002040666A2 Fat regulated genes, uses thereof, and compounds for modulating same |
| 05/23/2002 | WO2002040649A1 Slo2 and slo4, novel potassium channel proteins from human brain |
| 05/23/2002 | WO2002040545A2 Reduction of the nonspecific animal toxicity of immunotoxins by mutating the framework regions of the fv to lower the isoelectric point |
| 05/23/2002 | WO2002040541A2 Transporters and ion channels |
| 05/23/2002 | WO2002040535A2 Compositions and methods relating to ovary specific genes and proteins |
| 05/23/2002 | WO2002040509A1 Antibody against norwalk virus and method of detecting virus by using the antibody |
| 05/23/2002 | WO2002040051A1 Colostrum-based composition |
| 05/23/2002 | WO2002040050A1 Non-lethal methods for conditioning a recipient for bone marrow transplantation |
| 05/23/2002 | WO2002040047A2 Method for treating thrombocytopenia with monoclonal ivig |
| 05/23/2002 | WO2002039997A2 Ace-2 modulating compounds and use thereof |
| 05/23/2002 | WO2002039885A2 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 05/23/2002 | WO2002039813A1 Pd-1-lacking mouse and use thereof |
| 05/23/2002 | WO2002015931A9 Immunologic method for the prevention of dental caries |
| 05/23/2002 | WO2002003911B1 Prevention and treatment of alzheimer's disease |
| 05/23/2002 | WO2001090182A3 Synthetic immunogenic but non-amyloidogenic peptides homologous to amyloid beta for induction of an immune response to amyloid beta and amyloid deposits |
| 05/23/2002 | WO2001085911A3 Chromosome 17p-linked prostate cancer susceptibility gene and a paralog and orthologous genes |
| 05/23/2002 | WO2001085792A8 Mu-1, member of the cytokine receptor family |
| 05/23/2002 | WO2001083755A3 Human anti-cd40 antibodies and methods of making and using same |
| 05/23/2002 | WO2001081577A3 Dna encoding the prost 03 polypeptide |
| 05/23/2002 | WO2001079444A3 Albumin fusion proteins |
| 05/23/2002 | WO2001073028A3 A p-selectin glycoprotein ligand (psgl-1) binding protein and uses therefor |
| 05/23/2002 | WO2001049720A3 Chemically modified hiv envelope glycoprotein |
| 05/23/2002 | WO2001040271A9 Cancer associated antigens and uses therefor |
| 05/23/2002 | WO2001037872A9 'bonzo' chemokine receptor antibodies and ligands |
| 05/23/2002 | WO2001029197A3 Novel germinal center kinase cell cycle proteins, compositions and methods of use |
| 05/23/2002 | US20020062488 Methods and compositions for modulating the interaction between the apj receptor and the hiv virus |
| 05/23/2002 | US20020062010 Generating polyclonal antibody; obtain cells, transform cell with expression vector coding preferential polypeptides, culture cells recover polyclonal antibody |
| 05/23/2002 | US20020062009 Monoclonal antibodies with reduced immunogenicity |